Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Activity heats up around Australian pharma pricing deal

This article was originally published in SRA

Executive Summary

Research-based drug industry association Medicines Australia has written to a senate committee urging that the Parliament should pass before 1 October a medicines pricing deal bill that aims to save taxpayers Aus$1.9 billion (US$1.7 billion) over a five-year period1-4. The Generic Medicines Industry Association (GMiA), meanwhile, has written to the same committee arguing against implementing the deal.

You may also be interested in...



Canada Boosts Postmarket Device Safety With New Reporting Rules

Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.

Global Regulators Seek Unified Approach To Remote Inspections

Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.

Canada Proposes 14 New Entries To List Of Recognized Device Standards

The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.

UsernamePublicRestriction

Register

OM011381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel